Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,040 | 11,353 | 11,276 | 12,432 | 15,312 |
| TOTAL | $8,870 | $12,312 | $12,013 | $13,328 | $16,266 |
| Non-Current Assets | |||||
| PPE Net | 3 | 4 | 5 | 10 | 10 |
| Other Non-Current Assets | 463 | 555 | 634 | 714 | 791 |
| TOTAL | $466 | $559 | $639 | $724 | $801 |
| Total Assets | $9,336 | $12,871 | $12,652 | $14,052 | $17,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 235 | 349 | N/A | 158 | 259 |
| Accounts payable and accrued liabilities | 366 | 514 | 459 | 698 | 950 |
| Accrued Expenses | 1,958 | 1,843 | 1,883 | 1,609 | 1,323 |
| TOTAL | $2,681 | $2,836 | $2,467 | $2,586 | $2,649 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 47 | 86 | 121 | 153 | 336 |
| TOTAL | $47 | $86 | $121 | $153 | $336 |
| Total Liabilities | $2,728 | $2,922 | $2,588 | $2,739 | $2,985 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,330 | 1,184 | 938 | 852 | 615 |
| Common Shares | 11 | 9 | 8 | 6 | 92 |
| Retained earnings | -132,600 | -129,113 | -125,033 | -121,506 | -118,535 |
| Other shareholders' equity | 2 | 2 | 2 | 2 | 2 |
| TOTAL | $6,608 | $9,949 | $10,064 | $11,313 | $14,082 |
| Total Liabilities And Equity | $9,336 | $12,871 | $12,652 | $14,052 | $17,067 |